EUVIMEDEUVIMED entdecken
Crossref

Upgrade Rate of Exclusively MRI-Detected Papillomas in Asymptomatic Patients Undergoing Screening or Extent of Disease Examinations

Kathryn Watts Zamora iD, Ceren Yalniz, Kudratjot Brar, Yufeng Li, Stefanie Zalasin, Stefanie Woodard iD

Journal of Breast Imaging · 2025

DOI: 10.1093/jbi/wbae080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Breast Imaging, 2025. Verfasst von Kathryn Watts Zamora und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of Alabama at Birmingham, Birmingham, AL, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Papilloma, Magnetic Resonance Imaging. Die Arbeit nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine the upgrade rate of exclusively MRI-detected benign papillomas in asymptomatic high-risk patients, patients with a history of cancer, or patients with known malignancy.

Methods

This IRB-approved retrospective study reviewed all breast MRI–guided biopsies yielding papilloma on pathology for all asymptomatic patients undergoing breast MRI for high-risk screening, newly diagnosed breast cancer, or a personal history of breast cancer. All cases were followed by excision or 2-year imaging follow-up. The upgrade rate was determined. Fisher’s exact test was used to determine the significance of associated factors, including lesion type, lesion size, and ipsilateral malignancy.

Results

Of the 258 MRI-guided biopsies, 117 met the inclusion criteria. A 4% (5/117) upgrade rate was found with a 3% (4/117) upgrade rate to ductal carcinoma in situ (DCIS) and a 1% (1/117) upgrade rate to invasive malignancy for all identified papillomas. When evaluating all papillomas, the only associated feature identified to be statically significant for risk of upgrade was ipsilateral malignancy with a 60% (3/5) upgrade rate with a P-value of .0057. When separately evaluating benign papillomas only by excluding those with atypia or additional high-risk lesion at biopsy, a 4% (3/80) upgrade rate to DCIS was found. There was no upgrade to invasive malignancy.

Conclusion

Upgrade of MRI-detected papillomas in asymptomatic high-risk patients, patients with a history of cancer, or patients with known malignancy is 4% in this population, which suggests these lesions may warrant surgical excision.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsPapillomaMagnetic Resonance ImagingHumansFemaleRetrospective StudiesMiddle AgedAgedAdultImage-Guided BiopsyAsymptomatic DiseasesBreast

Stichwörter der Autor:innen

breast MRI clinical applicationsbreast cancer risk assessmentbreast pathologybreast procedurespapilloma

Autor:innen und Institutionen

  • Department of Radiology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Department of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

ORCID-Profile: Kathryn Watts Zamora, Stefanie Woodard

Zitieren

APA

Zamora, K. W., Yalniz, C., Brar, K., Li, Y., Zalasin, S., & Woodard, S. (2025). Upgrade Rate of Exclusively MRI-Detected Papillomas in Asymptomatic Patients Undergoing Screening or Extent of Disease Examinations. Journal of Breast Imaging. https://doi.org/10.1093/jbi/wbae080

Vancouver

Zamora KW, Yalniz C, Brar K, Li Y, Zalasin S, Woodard S. Upgrade Rate of Exclusively MRI-Detected Papillomas in Asymptomatic Patients Undergoing Screening or Extent of Disease Examinations. Journal of Breast Imaging. 2025. doi:10.1093/jbi/wbae080

BibTeX
@article{Zamora2025,
  author = {Zamora, Kathryn Watts and Yalniz, Ceren and Brar, Kudratjot and Li, Yufeng and Zalasin, Stefanie and Woodard, Stefanie},
  title = {Upgrade Rate of Exclusively MRI-Detected Papillomas in Asymptomatic Patients Undergoing Screening or Extent of Disease Examinations},
  journal = {Journal of Breast Imaging},
  year = {2025},
  doi = {10.1093/jbi/wbae080}
}
Kostenlos starten →